Search Results - "Emole, Josephine"

Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States by Emole, Josephine, Lawal, Odunayo, Lupak, Oleksandra, Dias, Ajoy, Shune, Leyla, Yusuf, Korede

“…Background It is not clear if all Americans have benefitted equally from the availability of chimeric antigen receptor T‐cell (CART) therapy. We aimed to…”
Get full text

Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial by Farhan, Shatha, Mazur, Izabela, Hartzell, Susan, Xie, Peter, Neme, Klodiana, German, Angela, Mikulandric, Nancy, Patel, Kunj, Wu, Min, Kortam, Neda, Yaseen, Aseel, Sweidan, Aroob, Latack, Katie, Emole, Josephine, Peres, Edward, Abidi, Muneer H., Ramesh, Mayur

“…•No difference in bloodstream infections between ciprofloxacin and levofloxacin.•No difference in other secondary outcomes.•Pneumonia was more frequent in the…”
Get full text

Neuropsychiatric disorders in adults undergoing chimeric antigen receptor T cells therapy for aggressive lymphomas and acute lymphoblastic leukemia by Emole, Josephine, Lawal, Odunayo, Lupak, Oleksandra, Rangarajan, Hemalatha, Udo, Itoro

“…•Nearly one-third of hospitalized patients who had chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia and aggressive lymphomas in 2018…”
Get full text

Electrocardiographic Changes Associated With Ibrutinib Exposure by Fradley, Michael G., Welter-Frost, Allan, Gliksman, Matthew, Emole, Josephine, Viganego, Federico, Lee, Dae Hyun, Shah, Bijal, Chavez, Julio C., Pinilla-Ibarz, Javier, Schabath, Matthew B.

“…Although ibrutinib-associated atrial and ventricular arrhythmias have been well described, there is little information about ibrutinib’s effects on other…”
Get full text

A Case of Right Ventricular Failure Secondary to Acute Chest Syndrome Managed With Early Red Cell Exchange Transfusion by Geletu, Abeselom, Emole, Josephine, Abu Sayf, Alaa, Hinojosa, Oscar A, Gastesi, Alexandra

“…Patients with sickle cell disease are at risk of vaso-occlusive crises including acute chest syndrome (ACS) and pulmonary hypertension. ACS is a…”
Get full text

An update on current and prospective immunotherapies for chronic lymphocytic leukemia by Emole, Josephine N, Locke, Frederick L, Pinilla-Ibarz, Javier

“…Chronic lymphocytic leukemia (CLL) is the most common leukemia. Combined agent chemotherapy is the current standard front-line treatment for physically fit…”
Get full text

A national study of allogeneic stem cell transplantation for adults with acute myeloid leukemia: Do gender and age above 70 years matter? by Emole, Josephine, Shune, Leyla, Lupak, Oleksandra, Dias, Ajoy Lawrence

“…Abstract only e19020 Background: Allogeneic stem cell transplantation (alloSCT) is increasingly being offered to older patients with acute myeloid leukemia…”
Get full text

Pulmonary fungal infections in acute leukemias and aggressive lymphomas: Analysis of the United States National Inpatient Database by Ozoya, Oluwatobi, Ayuk, Adaeze, Lawal, Odunayo, Emole, Josephine

“…Abstract only e19042 Background: For patients undergoing intensive chemotherapy, pulmonary fungal infections (PFI) represent a major cause of morbidity and…”
Get full text

Neuropsychiatric disorders in hospitalized patients undergoing chimeric antigen receptor T-cell therapy for aggressive lymphomas and acute lymphoblastic leukemia: A national study by Emole, Josephine, Lawal, Odunayo Susan, Lupak, Oleksandra, Udo, Itoro

“…Abstract only 12118 Background: Chimeric antigen receptor T cell therapy (CART) has shown efficacy in acute lymphoblastic leukemia (ALL), diffuse large B cell…”
Get full text

Standard Risk Assessment Tools Fall Short to Assess Risk in Transplant Patients by Kulkarni, Radhika, Gonzalez-Mosquera, Luis Fernando, Abidi, Muneer H., Emole, Josephine, Peres, Edward M., Farhan, Shatha Y.

“…Introduction: The HCT-CI (Hematopoietic Cell Transplantation-specific Comorbidity Index) predicts survival after HCT in patients with hematologic malignancies…”
Get full text

Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist by Pinilla-Ibarz, Javier, Emole, Josephine

“…Chronic lymphocytic leukemia (CLL), the most prevalent leukemia in the Western world, is predominantly a disease of older individuals who also have other…”
Get more information

Poster: CT-423: Neuropsychiatric Disorders in Hospitalized Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma by Lawal, Odunayo, Lupak, Oleksandra, Udo, Itoro, Emole, Josephine

Get full text

CT-423: Neuropsychiatric Disorders in Hospitalized Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma by Lawal, Odunayo, Lupak, Oleksandra, Udo, Itoro, Emole, Josephine

“…Chimeric antigen receptor T-cell (CAR-T) therapies have shown efficacy in treatment of relapsed/refractory multiple myeloma (MM). Neuropsychiatric disorders…”
Get full text

Long-term BCR-ABL1 Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia by Pinilla-Ibarz, Javier, Sweet, Kendra, Emole, Josephine, Fradley, Michael

“…With the success of tyrosine kinase inhibitor (TKI) therapy for the treatment of patients with chronic myeloid leukemia (CML), CML is now treated as a chronic…”
Get full text

Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy by Fradley, Michael G., Gliksman, Matthew, Emole, Josephine, Viganego, Federico, Rhea, Isaac, Welter-Frost, Allan, Armanious, Merna, Lee, Dae Hyun, Walko, Christine, Shah, Bijal, Chavez, Julio C., McLeod, Howard, Pinilla-Ibarz, Javier, Schabath, Matthew B.

“…There is increasing evidence that rates of atrial arrhythmias (AA), specifically atrial fibrillation and flutter are elevated in patients treated with the…”
Get full text

Outcomes of tbo-filgrastim, filgrastim-sndz or filgrastim for mobilization in patients undergoing an autologous hematopoietic stem cell transplant: A single center experience by Neme, Klodiana, Henkin, David, Mikulandric, Nancy, Grycki, Meredith, Michael, Angela, Smith, Cassandra, Emole, Josephine

“…Abstract only e19000 Background: Studies have reported that use of filgrastim (G) or any biosimilar result in similar stem cell yield during hematopoietic stem…”
Get full text

Etanercept with extracorporeal photopheresis (ECP) for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation by Singh, Sunny R K, Malapati, Sindhu Janarthanam, Neme, Klodiana, Michael, Angela, Mikulandric, Nancy, Vulaj, Vera, Emole, Josephine

“…Abstract only 7543 Background: Acute graft versus host disease (aGVHD) is a well-described complication of allogeneic stem cell transplantation (allo-SCT)…”
Get full text

Disparities in Utilization of Autologous Stem Cell Transplantation as Consolidative Therapy for Multiple Myeloma: A Single Institution Retrospective Review by Lupak, Oleksandra, Xiaoxia, Han, Xie, Peter, Thanikachalam, Kannan, Jabbour-Aida, Hiba, Farhan, Shatha, Emole, Josephine

“…Most guidelines recommend induction therapy followed by autologous hematopoietic cell transplantation. A Surveillance, Epidemiology, and End Results–Medicare…”
Get full text

Association between ibrutinib treatment and hypertension by Lee, Dae Hyun, Hawk, Fahad, Seok, Kieun, Gliksman, Matthew, Emole, Josephine, Rhea, Isaac B, Viganego, Federico, Welter-Frost, Allan, Armanious, Merna, Shah, Bijal, Chavez, Juliio C, Pinilla-Ibarz, Javier, Schabath, Matthew B, Fradley, Michael

“…Ibrutinib is a tyrosine kinase inhibitor most commonly associated with atrial fibrillation. However, additional cardiotoxicities have been identified,…”
Get more information

Disparities in utilization of autologous stem cell transplantation as consolidative therapy for multiple myeloma: A single-institution retrospective review by Lupak, Oleksandra, Han, Xiaoxia, Patil, Neha, Thanikachalam, Kannan, Xie, Peter, Jabbour, Hiba, Al Saheli, Zaid, Malapati, Sindhu Janarthanam, Farhan, Shatha Younis-Mustafa, Emole, Josephine

“…Abstract only e20504 Background: Multiple Myeloma (MM) accounts for about 17% of hematologic malignancies in the United States. It is a disease of older…”
Get full text